Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Abstract 1430: N-cadherin is a driver of adaptive radioresistance in malignant brain tumors

Satoru Osuka, Dan Zhu, Zhaobin Zhang, Chaoxi Li, Christian T. Stackhouse, Oltea Sampetrean, Jeffrey J. Olson, G. Yancey Gillespie, Hideyuki Saya, Christopher D. Willey, Erwin G. Van Meir

Cancer Res (2022) 82 (12_Supplement): 1430.

https://doi.org/10.1158/1538-7445.AM2022-1430

Published: 15 June 2022

View articletitled, Abstract 1430: N-cadherin is a driver of adaptive radioresistance in malignant brain tumors

Journal Articles

Abstract CT018: Phase I immunovirotherapy trial of oncolytic HSV-1 G207 alone or combined with radiation in pediatric high-grade glioma

Cancer Res (2021) 81 (13_Supplement): CT018.

https://doi.org/10.1158/1538-7445.AM2021-CT018

Published: 01 July 2021

View articletitled, Abstract CT018: Phase I immunovirotherapy trial of oncolytic HSV-1 G207 alone or combined with radiation in pediatric high-grade glioma

Journal Articles

Abstract 3078: IGF1/N-cadherin/b-catenin/Clusterin signaling axis can mediates adaptive radioresistance in glioblastoma

Satoru Osuka, Dan Zhu, Zhaobin Zhang, Chaoxi Li, Christian T. Stackhouse, Oltea Sampetrean, Jeffrey J. Olson, G. Yancey Gillespie, Hideyuki Saya, Christopher D. Willey, Erwin G. Van Meir

Cancer Res (2021) 81 (13_Supplement): 3078.

https://doi.org/10.1158/1538-7445.AM2021-3078

Published: 01 July 2021

View articletitled, Abstract 3078: IGF1/N-cadherin/b-catenin/Clusterin signaling axis can mediates adaptive radioresistance in glioblastoma

Journal Articles

Abstract 279: Long non-coding RNAs in glioblastoma tumor recurrence and therapy resistance

Christian Tyler Stackhouse, James R. Rowland, Jelai Wang, Thanh Nguyen, Zongliang Yue, Jake Y. Chen, Lara Ianov, G. Yancey Gillespie, Christopher D. Willey

Cancer Res (2020) 80 (16_Supplement): 279.

https://doi.org/10.1158/1538-7445.AM2020-279

Published: 15 August 2020

View articletitled, Abstract 279: Long non-coding RNAs in glioblastoma tumor recurrence and therapy resistance

Journal Articles

Abstract LB-204: SON controls the oncogenic alternative splicing program in glioblastoma by regulating PTBP1/2 switch and RBFOX2 activity

Jung-Hyun Kim, Joshua K. Stone, Jianfeng Li, Alexander Richard, Lana Vukadin, G. Yancey Gillespie, Robert W. Sobol, Steve Lim, Eun-Young Erin Ahn

Cancer Res (2018) 78 (13_Supplement): LB-204.

https://doi.org/10.1158/1538-7445.AM2018-LB-204

Published: 01 July 2018

View articletitled, Abstract LB-204: SON controls the oncogenic alternative splicing program in glioblastoma by regulating PTBP1/2 switch and RBFOX2 activity

Journal Articles

Abstract 163: Glioblastoma, cancer stem cells, and reactive species balances: A case for GTP cyclohydrolase 1

Anh N. Tran, Kiera Walker, David G. Harrison, Wei Chen, James Mobley, Lauren Hocevar, James R. Hackney, Randee Sedaka, Jennifer Pollock, Matthew S. Goldberg, Dolores Hambardzumyan, Sara J. Cooper, G Yancey Gillespie, Anita B. Hjelmeland

Cancer Res (2018) 78 (13_Supplement): 163.

https://doi.org/10.1158/1538-7445.AM2018-163

Published: 01 July 2018

View articletitled, Abstract 163: Glioblastoma, cancer stem cells, and reactive species balances: A case for GTP cyclohydrolase 1

Journal Articles

Abstract A16: Combinatorial drug testing using 3D microtumors derived from GBM PDX reveals cytotoxic synergisms in pharmacokinomics-informed pathway interactions

Christopher D. Willey, Ashley N. Gilbert, Rachael Shevin, Catherine P. Langford, Christine W. Duarte, Raj Singh, Joshua C. Anderson, G. Yancey Gillespie

Cancer Res (2015) 75 (23_Supplement): A16.

https://doi.org/10.1158/1538-7445.BRAIN15-A16

Published: 09 December 2015

View articletitled, Abstract A16: Combinatorial drug testing using 3D microtumors derived from GBM PDX reveals cytotoxic synergisms in pharmacokinomics-informed pathway interactions

Journal Articles

Abstract 312: Profiling drug sensitivity and kinomic pathways utilizing a novel human tumor derived MicroTumor assay

Christopher D. Willey, Ashley N. Gilbert, Rachael Shevin, Catherine P. Langford, Raj Singh, Joshua C. Anderson, G. Yancey Gillespie

Cancer Res (2015) 75 (15_Supplement): 312.

https://doi.org/10.1158/1538-7445.AM2015-312

Published: 01 August 2015

View articletitled, Abstract 312: Profiling drug sensitivity and kinomic pathways utilizing a novel human tumor derived MicroTumor assay

Journal Articles

Abstract 530: Circulating γδ T cells are activated and depleted during progression of high-grade gliomas: Implications for γδ T cells therapy of GBM

Benjamin Beck, G Yancey Gillespie, Richard D. Lopez, Gretchen A. Cloud, Cathy Langford, Hyung Kim, Lualhati Harkins, Lawrence S. Lamb

Cancer Res (2012) 72 (8_Supplement): 530.

https://doi.org/10.1158/1538-7445.AM2012-530

Published: 15 April 2012

View articletitled, Abstract 530: Circulating γδ T cells are activated and depleted during progression of high-grade gliomas: Implications for γδ T cells therapy of GBM

Journal Articles

Abstract 1905: Autophagy inhibitor quinacrine synergistically enhances anti-angiogenic efficacy of Cediranib in intracranial mouse glioma

Merryl R. Lobo, Elaine T. Huang, Peter Kurre, Matthias C. Schabel, G. Yancey Gillespie, Martin M. Pike

Cancer Res (2012) 72 (8_Supplement): 1905.

https://doi.org/10.1158/1538-7445.AM2012-1905

Published: 15 April 2012

View articletitled, Abstract 1905: Autophagy inhibitor quinacrine synergistically enhances anti-angiogenic efficacy of Cediranib in intracranial mouse glioma

Journal Articles

Abstract 1942: Vδ1+ γδ T cells are cytotoxic against glioblastoma multiforme

Andrea Knight, Hilal Arnouk, William Britt, G Yancey Gillespie, Mark W. Lowdell, Gretchen A. Cloud, James M. Markert, Catherine P. Langford, Yun Su, Lawrence S. Lamb

Cancer Res (2010) 70 (8_Supplement): 1942.

https://doi.org/10.1158/1538-7445.AM10-1942

Published: 15 April 2010

View articletitled, Abstract 1942: Vδ1+ γδ T cells are cytotoxic against glioblastoma multiforme

Journal Articles

Expression of glioma stem cell marker CD133 is regulated by hypoxia and mitochondrial dysfunction

Corinne Griguer, Claudia Oliva, G. Yancey Gillespie

Cancer Res (2008) 68 (9_Supplement): 3770.

Published: 01 May 2008

View articletitled, Expression of glioma stem cell marker CD133 is regulated by hypoxia and mitochondrial dysfunction

Journal Articles

Tristetraprolin Down-regulates Interleukin-8 and Vascular Endothelial Growth Factor in Malignant Glioma Cells

Esther Suswam, Yanyan Li, Xiaowen Zhang, G. Yancey Gillespie, Xuelin Li, John J. Shacka, Liang Lu, Lei Zheng, Peter H. King

Cancer Res (2008) 68 (3): 674–682.

https://doi.org/10.1158/0008-5472.CAN-07-2751

Published: 01 February 2008

View articletitled, Tristetraprolin Down-regulates Interleukin-8 and Vascular Endothelial Growth Factor in Malignant Glioma Cells

Journal Articles

Systemic anti-HGF monoclonal antibody therapy induces regression of intracranial glioma xenograft

K. Jin Kim, Lihong Wang, Yi-Chi Su, G. Yancey Gillespie, Amandeep Salhotra, Bachchu Lal, John Laterra

Cancer Res (2006) 66 (8_Supplement): 276.

Published: 15 April 2006

View articletitled, Systemic anti-HGF monoclonal antibody therapy induces regression of intracranial glioma xenograft

Journal Articles

The type 1 repeat peptide ABT510 induces apoptosis of brain microvascular endothelial cells and inhibits glioblastoma tumor growth in vivo

Joshua C. Anderson, John R. Grammer, Louis B. Nabors, III, G. Yancey Gillespie, Jack Henkin, Jerry E. Stewart, Jr., Candece L. Gladson

Cancer Res (2006) 66 (8_Supplement): 54.

Published: 15 April 2006

View articletitled, The type 1 repeat peptide ABT510 induces apoptosis of brain microvascular endothelial cells and inhibits glioblastoma tumor growth in vivo

Journal Articles

Influence of tumor-conditioned medium on hypoxia-mediated inhibition of growth and survival of endothelial cells

Rave Sanker Ezhilarasan, Kathiravan Govindarajan, Indra Mohanam, Jasti S. Rao, G. Yancey Gillespie, Sanjeeva Mohanam

Cancer Res (2006) 66 (8_Supplement): 657.

Published: 15 April 2006

View articletitled, Influence of tumor-conditioned medium on hypoxia-mediated inhibition of growth and survival of endothelial cells

Journal Articles

Xanthine Oxidase–Dependent Regulation of Hypoxia-Inducible Factor in Cancer Cells

Corinne E. Griguer, Claudia R. Oliva, Eric E. Kelley, Gregory I. Giles, Jack R. Lancaster, Jr., G. Yancey Gillespie

Cancer Res (2006) 66 (4): 2257–2263.

https://doi.org/10.1158/0008-5472.CAN-05-3364

Published: 17 February 2006

View articletitled, Xanthine Oxidase–Dependent Regulation of Hypoxia-Inducible Factor in Cancer Cells

Journal Articles

Lyn Kinase Activity Is the Predominant Cellular Src Kinase Activity in Glioblastoma Tumor Cells

Michelle R. Stettner, Wenquan Wang, L. Burton Nabors, Suman Bharara, Daniel C. Flynn, J. Robert Grammer, G. Yancey Gillespie, Candece L. Gladson

Cancer Res (2005) 65 (13): 5535–5543.

https://doi.org/10.1158/0008-5472.CAN-04-3688

Published: 01 July 2005

View articletitled, Lyn Kinase Activity Is the Predominant Cellular Src Kinase Activity in Glioblastoma Tumor Cells

Journal Articles

Lyn kinase activity in glioblastomas: expression of constitutively active Lyn promotes PDGF-stimulated migration and invasion of glioblastoma cells

Michelle R. Stettner, Wenquan Wang, L. Burt Nabors, Suman Bharara, Daniel C. Flynn, J. Robert Grammer, G. Yancey Gillespie, Candece L. Gladson

Cancer Res (2005) 65 (9_Supplement): 1080.

Published: 01 May 2005

View articletitled, Lyn kinase activity in glioblastomas: expression of constitutively active Lyn promotes PDGF-stimulated migration and invasion of glioblastoma cells

Journal Articles

Transcriptional Targeting of Adenovirally Delivered Tumor Necrosis Factor α by Temozolomide in Experimental Glioblastoma

Bakhtiar Yamini, Xiaohong Yu, G. Yancey Gillespie, Donald W. Kufe, Ralph R. Weichselbaum

Cancer Res (2004) 64 (18): 6381–6384.

https://doi.org/10.1158/0008-5472.CAN-04-2117

Published: 16 September 2004

View articletitled, Transcriptional Targeting of Adenovirally Delivered Tumor Necrosis Factor α by Temozolomide in Experimental Glioblastoma

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

Abstract 1430: N-cadherin is a driver of adaptive radioresistance in malignant brain tumors

Abstract CT018: Phase I immunovirotherapy trial of oncolytic HSV-1 G207 alone or combined with radiation in pediatric high-grade glioma

Abstract 3078: IGF1/N-cadherin/b-catenin/Clusterin signaling axis can mediates adaptive radioresistance in glioblastoma

Abstract 279: Long non-coding RNAs in glioblastoma tumor recurrence and therapy resistance

Abstract LB-204: SON controls the oncogenic alternative splicing program in glioblastoma by regulating PTBP1/2 switch and RBFOX2 activity

Abstract 163: Glioblastoma, cancer stem cells, and reactive species balances: A case for GTP cyclohydrolase 1

Abstract A16: Combinatorial drug testing using 3D microtumors derived from GBM PDX reveals cytotoxic synergisms in pharmacokinomics-informed pathway interactions

Abstract 312: Profiling drug sensitivity and kinomic pathways utilizing a novel human tumor derived MicroTumor assay

Abstract 530: Circulating γδ T cells are activated and depleted during progression of high-grade gliomas: Implications for γδ T cells therapy of GBM

Abstract 1905: Autophagy inhibitor quinacrine synergistically enhances anti-angiogenic efficacy of Cediranib in intracranial mouse glioma

Abstract 1942: Vδ1+ γδ T cells are cytotoxic against glioblastoma multiforme

Expression of glioma stem cell marker CD133 is regulated by hypoxia and mitochondrial dysfunction

Tristetraprolin Down-regulates Interleukin-8 and Vascular Endothelial Growth Factor in Malignant Glioma Cells

Systemic anti-HGF monoclonal antibody therapy induces regression of intracranial glioma xenograft

The type 1 repeat peptide ABT510 induces apoptosis of brain microvascular endothelial cells and inhibits glioblastoma tumor growth in vivo

Influence of tumor-conditioned medium on hypoxia-mediated inhibition of growth and survival of endothelial cells

Xanthine Oxidase–Dependent Regulation of Hypoxia-Inducible Factor in Cancer Cells

Lyn Kinase Activity Is the Predominant Cellular Src Kinase Activity in Glioblastoma Tumor Cells

Lyn kinase activity in glioblastomas: expression of constitutively active Lyn promotes PDGF-stimulated migration and invasion of glioblastoma cells

Transcriptional Targeting of Adenovirally Delivered Tumor Necrosis Factor α by Temozolomide in Experimental Glioblastoma

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only